Is ABUS or CRVS more profitable?

ABUS runs the higher net margin — ABUS at 84.23% versus CRVS at 0.00%.

How have ABUS and CRVS total returns compared?

Over the past 10 years, ABUS delivered 2.93% and CRVS delivered -4.26% annualized total return. Past performance doesn't predict future results.

Arbutus Biopharma Corp (ABUS) vs Corvus Pharmaceuticals, Inc. (CRVS)

A side-by-side comparison of Arbutus Biopharma Corp and Corvus Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABUS

Arbutus Biopharma Corp

$897M

$4.54HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT

CRVS

Corvus Pharmaceuticals, Inc.

$886M

$10.53HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT

Total return — ABUS vs CRVS

growth of $100 · dividends reinvested · last 10y

ABUS +38.6% (+3.3%/yr)CRVS -33.9% (-4.1%/yr)ABUS compounded faster over this window

ABUS CRVS

ABUS vs CRVS: by the numbers

•ABUS is the larger company ($897M vs $886M market cap).
•ABUS is profitable (84.23% net margin) while CRVS runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	ABUS	CRVS
P/E ratio	5.82	N/A
Forward P/E	6.14	N/A
P/S ratio	4.94	N/A
P/B ratio	3.47	3.93
EV / EBITDA	5.98	N/A

Profitability

Metric	ABUS	CRVS
Gross margin	99.98%	0.00%
Operating margin	-192.08%	0.00%
Net margin	84.23%	0.00%
ROE	59.16%	-24.02%
ROIC	54.39%	-25.25%

Growth (annualized)

Metric	ABUS	CRVS
Revenue CAGR (5Y)	85.17%	N/A
Total return CAGR (5Y)	2.19%	17.88%

Frequently asked

Is ABUS or CRVS more profitable?: ABUS runs the higher net margin — ABUS at 84.23% versus CRVS at 0.00%.
How have ABUS and CRVS total returns compared?: Over the past 10 years, ABUS delivered 2.93% and CRVS delivered -4.26% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABUS analysis Full CRVS analysis Interactive comparison tool

Dig into the metrics

Arbutus Biopharma P/E ratio Arbutus Biopharma ROE Corvus Pharmaceuticals ROE Arbutus Biopharma operating margin Corvus Pharmaceuticals operating margin Arbutus Biopharma revenue growth Corvus Pharmaceuticals revenue growth Arbutus Biopharma free cash flow Corvus Pharmaceuticals free cash flow

Arbutus Biopharma & Corvus Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.